1. Home
  2. NDLS vs INKT Comparison

NDLS vs INKT Comparison

Compare NDLS & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NDLS
  • INKT
  • Stock Information
  • Founded
  • NDLS 1995
  • INKT 2017
  • Country
  • NDLS United States
  • INKT United States
  • Employees
  • NDLS N/A
  • INKT N/A
  • Industry
  • NDLS Restaurants
  • INKT Medicinal Chemicals and Botanical Products
  • Sector
  • NDLS Consumer Discretionary
  • INKT Health Care
  • Exchange
  • NDLS Nasdaq
  • INKT Nasdaq
  • Market Cap
  • NDLS 34.3M
  • INKT 36.7M
  • IPO Year
  • NDLS 2013
  • INKT 2021
  • Fundamental
  • Price
  • NDLS $1.10
  • INKT $8.18
  • Analyst Decision
  • NDLS Strong Buy
  • INKT Strong Buy
  • Analyst Count
  • NDLS 2
  • INKT 2
  • Target Price
  • NDLS $3.00
  • INKT $19.50
  • AVG Volume (30 Days)
  • NDLS 156.5K
  • INKT 11.3K
  • Earning Date
  • NDLS 03-06-2025
  • INKT 03-18-2025
  • Dividend Yield
  • NDLS N/A
  • INKT N/A
  • EPS Growth
  • NDLS N/A
  • INKT N/A
  • EPS
  • NDLS N/A
  • INKT N/A
  • Revenue
  • NDLS $493,271,000.00
  • INKT N/A
  • Revenue This Year
  • NDLS $2.24
  • INKT N/A
  • Revenue Next Year
  • NDLS $1.18
  • INKT N/A
  • P/E Ratio
  • NDLS N/A
  • INKT N/A
  • Revenue Growth
  • NDLS N/A
  • INKT N/A
  • 52 Week Low
  • NDLS $0.55
  • INKT $4.56
  • 52 Week High
  • NDLS $2.36
  • INKT $19.00
  • Technical
  • Relative Strength Index (RSI)
  • NDLS 40.13
  • INKT 42.71
  • Support Level
  • NDLS $1.20
  • INKT $7.90
  • Resistance Level
  • NDLS $1.57
  • INKT $8.43
  • Average True Range (ATR)
  • NDLS 0.12
  • INKT 0.81
  • MACD
  • NDLS -0.05
  • INKT -0.19
  • Stochastic Oscillator
  • NDLS 0.00
  • INKT 8.07

About NDLS Noodles & Company

Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.

Share on Social Networks: